Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Protopsaltis, Ioannis ^a   Foussas, Stefanos ^a   Angelidi, Angeliki ^a   Gritzapis, Angelos ^b   Sergentanis, Theodoros ^c   Matsagos, Spyros ^a   Tzirogiannis, Konstantinos ^a   Panoutsopoulos, Georgios I ^d   Dimitriadis, Georgios ^e   Raptis, Sotirios ^f   Melidonis, Andreas ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b Laboratory of Cellular Biology and Immunology   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF PELOPONNESE   (Greece)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f Hellenic National Diabetic Centre   (Greece)

Author keywords

ADMA; Endothelial progenitor cells; Pre diabetes; Pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; ENDOTHELIAL PROGENITOR CELL; EXERCISE; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SMOKING; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; ARGININE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FASTING; FEMALE; FEMORAL ARTERY; GLUCOSE TOLERANCE TEST; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; STEM CELLS; VASCULAR STIFFNESS;

EID: 84868690228     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-141     Document Type: Article

References (54)

1. Ackermann RT, Cheng YJ, Williamson DF, Gregg EW. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. Am J Prev Med 2011, 40:11-17. 10.1016/j.amepre.2010.09.022, 21146762.
2. Festa A, D'Agostino R, Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004, 53:1549-1555. 10.2337/diabetes.53.6.1549, 15161760.
3. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:932-943. 10.1161/01.ATV.0000160548.78317.29, 15731494.
4. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol 2010, 55:1318-1327. 10.1016/j.jacc.2009.10.061, 20338492.
5. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 2004, 43:176-181. 10.1161/01.HYP.0000111829.46090.92, 14698999.
6. Shin JY, Lee HR, Lee DC. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 2011, 10:30. 10.1186/1475-2840-10-30, 3098149, 21492487.
7. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000, 105:311-320. 10.1172/JCI7535, 377440, 10675357.
8. Ford CM, Pickering JG. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells: involvement of the AT1 receptor, transforming growth factor-beta and thyroid phosphorylation. Atheroscler Thromb Vasc Biol 1999, 19:1843-1851.
9. Wautier JL, Guillausseau PJ. Diabetes, advanced glycation end products and vascular disease. Vasc Med 1998, 3:131-137.
10. Sciacqua A, Maio R, Miceli S, Pascale A, Carullo G, Grillo N, Arturi F, Sesti G, Perticone F. Association between One-Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension. PLoS One 2012, 7:e44470. 10.1371/journal.pone.0044470, 3441532, 23028545.
11. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002, 105:213-217. 10.1161/hc0202.101970, 11790703.
12. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353. 10.1161/01.RES.0000137877.89448.78, 15321944.
13. Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A, Di Stefano R, Miccoli R, de Kreutzenberg S, Coracina A, Tiengo A, Agostini C, Del Prato S, Avogaro A. Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 2007, 50:2156-2163. 10.1007/s00125-007-0732-y, 17579827.
14. Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2011, 10:113. 10.1186/1475-2840-10-113, 3258289, 22185563.
15. Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 2009, 82:261-271.
16. Böger RH, Bode-Böger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost 2000, 26:539-545. 10.1055/s-2000-13210, 11129410.
17. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 2005, 46:1693-1701. 10.1016/j.jacc.2005.04.066, 16256870.
18. Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Correlates of arterial stiffness in an ageing population: Role of asymmetric dimethylarginine. Pharmacol Res 2009, 60:503-507. 10.1016/j.phrs.2009.06.006, 19559793.
19. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 2001, 88:1201-1203. 10.1016/S0002-9149(01)02063-X, 11703973.
20. Vallance P. Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 2001, 358:2096-2097. 10.1016/S0140-6736(01)07229-4, 11784617.
21. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001, 104:2569-2575. 10.1161/hc4601.098514, 11714652.
22. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
23. Thomas HE, Avery PJ, Ahmed JM, Edwards R, Purcell I, Zaman AG, Arthur HM, Keanvey BD. Local vessel injury following percutaneous coronary intervention does not promote early mobilization of endothelial progenitor cells in the absence of myocardial necrosis. Heart 2009, 95:555-558.
24. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995, 26:485-490. 10.1161/01.HYP.26.3.485, 7649586.
25. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002, 15:445-452. 10.1016/S0895-7061(01)02326-3, 12022247.
26. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart study. Circulation 2010, 121:505-511. 10.1161/CIRCULATIONAHA.109.886655, 2836717, 20083680.
27. Palombo C, Kozakova M, Morizzo C, Gnesi L, Barsotti MC, Spontoni P, Massart F, Salvi P, Balbarini A, Saggese G, Di Stefano R, Federico G. Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol 2011, 10:88. 10.1186/1475-2840-10-88, 3198903, 21981808.
28. Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, Esmore DS. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991, 338:270-273. 10.1016/0140-6736(91)90415-L, 1677109.
29. Paik DC, Ramey WG, Dillon J, Tilson MD. The nitrite/elastin reaction: implications for in vivo degenerative effects. Connect Tissue Res 1997, 36:241-251. 10.3109/03008209709160224, 9512892.
30. Zhang WZ, Venardos K, Finch S, Kaye DM. Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation. Int J Biochem Cell Biol 2008, 40:920-928. 10.1016/j.biocel.2007.10.027, 18069040.
31. Smilde TJ, van den Berkmortel FW, Wollersheim H, van Langen H, Kastelein JJ, Stalenhoef AF. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest 2000, 30:473-480. 10.1046/j.1365-2362.2000.00654.x, 10849014.
32. Rizos EC, Agouridis AP, Elisaf MS. The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. Curr Vasc Pharmacol 2010, 8:638-644. 10.2174/157016110792006950, 20507272.
33. Chirinos JA, David R, Bralley JA, Zea-Diaz H, Munoz-Atahualpa E, Corrales-Medina F, Cuba-Bustinza C, Chirinos-Pacheco J, Medina-Lezama J. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study. Hypertension 2008, 52:1051-1059. 10.1161/HYPERTENSIONAHA.108.120352, 18852383.
34. Yang Z, Chen L, Su C, Xia WH, Wang Y, Wang JM, Chen F, Zhang YY, Wu F, Xu SY, Zhang XL, Tao J. Impaired endothelial progenitor cell activity is associated with reduced arterial elasticity in patients with essential hypertension. Clin Exp Hypertens 2010, 32:444-452. 10.3109/10641961003686435, 20939752.
35. Loomans C, de Koning E, Staal F, Rookmaaker M, Verseyden C, de Boer H, Verhaar M, Braam B, Rabelink T, Zonneveld AJ. Endothelial Progenitor Cell Dysfunction. A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes. Diabetes 2004, 53:195-199.
36. Angulo J, Rodriguez-Manas L, Peiro C, Neira M, Marin J, Sanchez-Ferrer CF. Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats. Naunyn-Schmiedebergs Arch Pharmacol 1998, 358:529-537. 10.1007/PL00005289, 9840421.
37. Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn study. Circulation 2003, 107:2089-2095. 10.1161/01.CIR.0000065222.34933.FC, 12695300.
38. Sengstock DM, Vaitkevicius PV, Supiano MA. Arterial Stiffness Is Related to Insulin Resistance in Nondiabetic Hypertensive Older Adults. J Clin Endocrinol Metab 2005, 90:2823-2827. 10.1210/jc.2004-1686, 15728211.
39. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonadonna RC. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002, 105:576-582. 10.1161/hc0502.103333, 11827922.
40. Tanaka H, DeSouza CA, Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998, 18:127-132. 10.1161/01.ATV.18.1.127, 9445266.
41. Nagai Y, Fleg JL, Kemper MK, Rywik TM, Earley CJ, Metter EJ. Carotid arterial stiffness as a surrogate for aortic stiffness: relationship between carotid artery pressure-strain elastic modulus and aortic pulse wave velocity. Ultrasound Med Biol 1999, 25:181-188. 10.1016/S0301-5629(98)00146-X, 10320307.
42. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, Cambien F, Benetos A. Angiotensin II type 1 receptor -153 A/G and 1166 A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001, 19:407-413. 10.1097/00004872-200103000-00008, 11288810.
43. McEniery CM, Yasmin Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal Vascular Aging: Differential Effects on Wave Reflection and Aortic Pulse Wave Velocity: The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005, 46:1753-1760. 10.1016/j.jacc.2005.07.037, 16256881.
44. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96:308-315. 10.1161/01.CIR.96.1.308, 9236450.
45. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012, 308:875-881. 10.1001/2012.jama.10503, 22948697.
46. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, Thomas F, Pannier B, Asmar R, Zureik M, Safar M, Guize L. Determinants of Accelerated Progression of Arterial Stiffness in Normotensive Subjects and in Treated Hypertensive Subjects Over a 6-Year Period. Circulation 2002, 105:1202-1207. 10.1161/hc1002.105135, 11889014.
47. Wildman RP, Farhat GN, Patel AS, Mackey RH, Brockwell S, Thompson T, Sutton-Tyrrell K. Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 2005, 45:187-192. 10.1161/01.HYP.0000152200.10578.5d, 15596570.
48. Liao D, Arnett DK, Tyroler HA, Riley WA, Chambless LE, Szklo M, Heiss G. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 1999, 34:201-206. 10.1161/01.HYP.34.2.201, 10454441.
49. Dermellis J, Paparetou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension 2005, 45:426-431. 10.1161/01.HYP.0000157818.58878.93, 15710784.
50. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?. J Mol Med 2004, 82:671-677. 10.1007/s00109-004-0580-x, 15322703.
51. Schernthaner G, Krzyzanowska K. Role of asymmetric dimethylarginine in cardiovascular disease and diabetes. Biomarkers Med 2008, 2:317-320.
52. Anderson JL, Carlquist JF, Roberts WL, Horne BD, May HT, Schwarz EL, Pasquali M, Nielson R, Kushnir MM, Rockwood AL, Bair TL, Muhlestein JB. Intermountain Heart Collaborative Study Group. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?. Am Heart J 2007, 153:67-73. 10.1016/j.ahj.2006.10.014, 17174641.
53. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002, 287:1420-1426. 10.1001/jama.287.11.1420, 11903029.
54. Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS. Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism 2002, 51:843-846. 10.1053/meta.2002.33349, 12077728.